18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
and 9 12 9 12 O
older 13 18 13 18 O

A 0 1 19 20 O
history 2 9 21 28 O
of 10 12 29 31 O
hypersensitivity 13 29 32 48 O
to 30 32 49 51 O
selumetinib 33 44 52 63 B-treatment
, 44 45 63 64 O
or 46 48 65 67 O
any 49 52 68 71 O
excipient 53 62 72 81 O
agents 63 69 82 88 O
( 70 71 89 90 O
e.g. 71 75 90 94 O
Captisol 76 84 95 103 B-treatment
or 85 87 104 106 O
TPGS- 88 93 107 112 B-treatment
a 94 95 113 114 O
water 96 101 115 120 O
soluble 102 109 121 128 O
form 110 114 129 133 O
of 115 117 134 136 O
Vitamin 118 125 137 144 O
E 126 127 145 146 O
) 127 128 146 147 O

Any 0 3 148 151 O
evidence 4 12 152 160 O
of 13 15 161 163 O
severe 16 22 164 170 O
or 23 25 171 173 O
uncontrolled 26 38 174 186 O
systemic 39 47 187 195 B-chronic_disease
disease 48 55 196 203 I-chronic_disease
, 55 56 203 204 O
including 57 66 205 214 O
, 66 67 214 215 O
but 68 71 216 219 O
not 72 75 220 223 O
limited 76 83 224 231 O
to 84 86 232 234 O
, 86 87 234 235 O
ongoing 88 95 236 243 O
or 96 98 244 246 O
active 99 105 247 253 B-chronic_disease
infection 106 115 254 263 I-chronic_disease
, 115 116 263 264 O
active 117 123 265 271 O
bleeding 124 132 272 280 B-chronic_disease
diatheses 133 142 281 290 I-chronic_disease
or 143 145 291 293 O
renal 146 151 294 299 B-treatment
transplant 152 162 300 310 I-treatment
, 162 163 310 311 O
including 164 173 312 321 O
any 174 177 322 325 O
patient 178 185 326 333 O
known 186 191 334 339 O
to 192 194 340 342 O
have 195 199 343 347 O
hepatitis 200 209 348 357 B-chronic_disease
B 210 211 358 359 I-chronic_disease
, 211 212 359 360 O
hepatitis 213 222 361 370 B-chronic_disease
C 223 224 371 372 I-chronic_disease
, 224 225 372 373 O
or 226 228 374 376 O
human 229 234 377 382 B-chronic_disease
immunodeficiency 235 251 383 399 I-chronic_disease
virus 252 257 400 405 I-chronic_disease
( 258 259 406 407 I-chronic_disease
HIV 259 262 407 410 I-chronic_disease

Any 0 3 411 414 O
prior 4 9 415 420 B-treatment
treatment 10 19 421 430 I-treatment
with 20 24 431 435 I-treatment
either 25 31 436 442 I-treatment
a 32 33 443 444 I-treatment
MEK 34 37 445 448 I-treatment
, 37 38 448 449 I-treatment
RAS 39 42 450 453 I-treatment
, 42 43 453 454 I-treatment
or 44 46 455 457 I-treatment
RAF 47 50 458 461 I-treatment
inhibitor 51 60 462 471 I-treatment
for 61 64 472 475 O
advanced 65 73 476 484 B-cancer
or 74 76 485 487 O
metastatic 77 87 488 498 B-cancer
NSCLC 88 93 499 504 I-cancer

Any 0 3 505 508 O
unresolved 4 14 509 519 O
toxicity 15 23 520 528 B-clinical_variable
> 24 25 529 530 O
CTCAE 26 31 531 536 B-lower_bound
grade 32 37 537 542 I-lower_bound
2 38 39 543 544 I-lower_bound
despite 40 47 545 552 O
optimal 48 55 553 560 O
care 56 60 561 565 O
/ 60 61 565 566 O
support 61 68 566 573 O
, 68 69 573 574 O
from 70 74 575 579 O
previous 75 83 580 588 B-treatment
anti 84 88 589 593 I-treatment
- 88 89 593 594 I-treatment
cancer 89 95 594 600 I-treatment
therapy 96 103 601 608 I-treatment
, 103 104 608 609 O
except 105 111 610 616 O
for 112 115 617 620 O
alopecia 116 124 621 629 B-chronic_disease
, 124 125 629 630 O
within 126 132 631 637 O
7 133 134 638 639 B-upper_bound
days 135 139 640 644 I-upper_bound
prior 140 145 645 650 I-upper_bound
to 146 148 651 653 O
Cycle 149 154 654 659 O
1 155 156 660 661 O
, 156 157 661 662 O
day 158 161 663 666 O
1 162 163 667 668 O

Brain 0 5 669 674 B-cancer
metastases 6 16 675 685 I-cancer
or 17 19 686 688 O
spinal 20 26 689 695 B-treatment
cord 27 31 696 700 I-treatment
compression 32 43 701 712 I-treatment
unless 44 50 713 719 O
asymptomatic 51 63 720 732 O
, 63 64 732 733 O
treated 65 72 734 741 B-treatment
and 73 76 742 745 I-treatment
stable 77 83 746 752 I-treatment
off 84 87 753 756 I-treatment
steroids 88 96 757 765 I-treatment
and 97 100 766 769 I-treatment
anti 101 105 770 774 I-treatment
- 105 106 774 775 I-treatment
convulsants 106 117 775 786 I-treatment
for 118 121 787 790 O
at 122 124 791 793 O
least 125 130 794 799 O
30 131 133 800 802 B-lower_bound
days 134 138 803 807 I-lower_bound

Caution 0 7 808 815 O
should 8 14 816 822 O
be 15 17 823 825 O
exercised 18 27 826 835 O
when 28 32 836 840 O
administering 33 46 841 854 O
paclitaxel 47 57 855 865 B-treatment
( 58 59 866 867 I-treatment
Taxol 59 64 867 872 I-treatment
) 64 65 872 873 I-treatment
concomitantly 66 79 874 887 O
with 80 84 888 892 O
medicines 85 94 893 902 B-treatment
known 95 100 903 908 O
to 101 103 909 911 O
inhibit 104 111 912 919 O
( 112 113 920 921 O
e.g. 113 117 921 925 O
ketoconazole 118 130 926 938 B-treatment
and 131 134 939 942 O
other 135 140 943 948 O
imidazole 141 150 949 958 B-treatment
antifungals 151 162 959 970 I-treatment
, 162 163 970 971 O
erythromycin 164 176 972 984 B-treatment
, 176 177 984 985 O
fluoxetine 178 188 986 996 B-treatment
, 188 189 996 997 O
gemfibrozil 190 201 998 1009 B-treatment
, 201 202 1009 1010 O
cimetidine 203 213 1011 1021 B-treatment
, 213 214 1021 1022 O
ritonavir 215 224 1023 1032 B-treatment
, 224 225 1032 1033 O
saquinavir 226 236 1034 1044 B-treatment
, 236 237 1044 1045 O
indinavir 238 247 1046 1055 B-treatment
and 248 251 1056 1059 O
nelfinavir 252 262 1060 1070 B-treatment
) 262 263 1070 1071 O
OR 264 266 1072 1074 O
induce 267 273 1075 1081 O
( 274 275 1082 1083 O
e.g. 275 279 1083 1087 O
rifampicin 280 290 1088 1098 B-treatment
, 290 291 1098 1099 O
carbamazepine 292 305 1100 1113 B-treatment
, 305 306 1113 1114 O
phenytoin 307 316 1115 1124 B-treatment
, 316 317 1124 1125 O
efavirenz 318 327 1126 1135 B-treatment
and 328 331 1136 1139 O
nevirapine 332 342 1140 1150 B-treatment
) 342 343 1150 1151 O
either 344 350 1152 1158 O
CYP2C8 351 357 1159 1165 O
or 358 360 1166 1168 O
CYP3A4 361 367 1169 1175 O
. 367 368 1175 1176 O
Based 369 374 1177 1182 O
on 375 377 1183 1185 O
the 378 381 1186 1189 O
in 382 384 1190 1192 O
vitro 385 390 1193 1198 O
data 391 395 1199 1203 O
and 396 399 1204 1207 O
SimCYP 400 406 1208 1214 O
simulations 407 418 1215 1226 O
, 418 419 1226 1227 O
selumetinib 420 431 1228 1239 B-treatment
is 432 434 1240 1242 O
considered 435 445 1243 1253 O
unlikely 446 454 1254 1262 O
to 455 457 1263 1265 O
perpetrate 458 468 1266 1276 O
clinically 469 479 1277 1287 O
significant 480 491 1288 1299 O
drug 492 496 1300 1304 O
- 496 497 1304 1305 O
drug 497 501 1305 1309 O
interaction 502 513 1310 1321 O
via 514 517 1322 1325 O
inhibition 518 528 1326 1336 O
or 529 531 1337 1339 O
induction 532 541 1340 1349 O
of 542 544 1350 1352 O
CYP 545 548 1353 1356 O
enzymes 549 556 1357 1364 O

Conception 0 10 1365 1375 O
while 11 16 1376 1381 O
on 17 19 1382 1384 O
treatment 20 29 1385 1394 B-treatment
must 30 34 1395 1399 O
be 35 37 1400 1402 O
avoided 38 45 1403 1410 O

Current 0 7 1411 1418 O
or 8 10 1419 1421 O
past 11 15 1422 1426 O
history 16 23 1427 1434 O
of 24 26 1435 1437 O
central 27 34 1438 1445 B-chronic_disease
serous 35 41 1446 1452 I-chronic_disease
retinopathy 42 53 1453 1464 I-chronic_disease
or 54 56 1465 1467 O
retinal 57 64 1468 1475 B-chronic_disease
vein 65 69 1476 1480 I-chronic_disease
occlusion 70 79 1481 1490 I-chronic_disease

ECOG 0 4 1491 1495 B-clinical_variable
Performance 5 16 1496 1507 I-clinical_variable
Status 17 23 1508 1514 I-clinical_variable
of 24 26 1515 1517 O
0 27 28 1518 1519 B-lower_bound
or 29 31 1520 1522 O
1 32 33 1523 1524 B-upper_bound

Estimated 0 9 1525 1534 B-clinical_variable
life 10 14 1535 1539 I-clinical_variable
expectancy 15 25 1540 1550 I-clinical_variable
, 25 26 1550 1551 O
in 27 29 1552 1554 O
the 30 33 1555 1558 O
judgment 34 42 1559 1567 O
of 43 45 1568 1570 O
the 46 49 1571 1574 O
investigator 50 62 1575 1587 O
, 62 63 1587 1588 O
which 64 69 1589 1594 O
will 70 74 1595 1599 O
permit 75 81 1600 1606 O
receipt 82 89 1607 1614 O
of 90 92 1615 1617 O
treatment 93 102 1618 1627 B-treatment
of 103 105 1628 1630 O
12 106 108 1631 1633 B-lower_bound
weeks 109 114 1634 1639 I-lower_bound
or 115 117 1640 1642 O
more 118 122 1643 1647 O

Female 0 6 1648 1654 B-gender
patients 7 15 1655 1663 I-gender
who 16 19 1664 1667 O
are 20 23 1668 1671 O
pregnant 24 32 1672 1680 B-pregnancy
or 33 35 1681 1683 O
breast 36 42 1684 1690 O
- 42 43 1690 1691 O
feeding 43 50 1691 1698 O
( 51 52 1699 1700 O
confirmation 52 64 1700 1712 O
that 65 69 1713 1717 O
the 70 73 1718 1721 O
patient 74 81 1722 1729 O
is 82 84 1730 1732 O
not 85 88 1733 1736 B-pregnancy
pregnant 89 97 1737 1745 I-pregnancy
must 98 102 1746 1750 O
be 103 105 1751 1753 O
by 106 108 1754 1756 O
a 109 110 1757 1758 O
negative 111 119 1759 1767 B-pregnancy
pregnancy 120 129 1768 1777 I-pregnancy
test 130 134 1778 1782 O
result 135 141 1783 1789 O
obtained 142 150 1790 1798 O
during 151 157 1799 1805 O
screening 158 167 1806 1815 O
; 167 168 1815 1816 O
pregnancy 169 178 1817 1826 O
testing 179 186 1827 1834 O
is 187 189 1835 1837 O
required 190 198 1838 1846 O
of 199 201 1847 1849 O
women 202 207 1850 1855 B-gender
of 208 210 1856 1858 O
childbearing 211 223 1859 1871 O
potential 224 233 1872 1881 O
but 234 237 1882 1885 O
not 238 241 1886 1889 O
required 242 250 1890 1898 O
for 251 254 1899 1902 O
post 255 259 1903 1907 O
- 259 260 1907 1908 O
menopausal 260 270 1908 1918 O
or 271 273 1919 1921 O
surgically 274 284 1922 1932 O
, 284 285 1932 1933 O
sterilized 286 296 1934 1944 O
women 297 302 1945 1950 O
) 302 303 1950 1951 O

Females 0 7 1952 1959 B-gender
of 8 10 1960 1962 O
child 11 16 1963 1968 O
bearing 17 24 1969 1976 O
potential 25 34 1977 1986 O
that 35 39 1987 1991 O
are 40 43 1992 1995 O
sexually 44 52 1996 2004 O
active 53 59 2005 2011 O
must 60 64 2012 2016 O
agree 65 70 2017 2022 B-contraception_consent
to 71 73 2023 2025 I-contraception_consent
either 74 80 2026 2032 I-contraception_consent
practice 81 89 2033 2041 I-contraception_consent
2 90 91 2042 2043 I-contraception_consent
medically 92 101 2044 2053 I-contraception_consent
accepted 102 110 2054 2062 I-contraception_consent
highly 111 117 2063 2069 I-contraception_consent
effective 118 127 2070 2079 I-contraception_consent
methods 128 135 2080 2087 I-contraception_consent
of 136 138 2088 2090 I-contraception_consent
contraception 139 152 2091 2104 I-contraception_consent
at 153 155 2105 2107 O
the 156 159 2108 2111 O
same 160 164 2112 2116 O
time 165 169 2117 2121 O
or 170 172 2122 2124 O
abstain 173 180 2125 2132 B-contraception_consent
from 181 185 2133 2137 I-contraception_consent
heterosexual 186 198 2138 2150 I-contraception_consent
intercourse 199 210 2151 2162 I-contraception_consent
from 211 215 2163 2167 O
the 216 219 2168 2171 O
time 220 224 2172 2176 O
of 225 227 2177 2179 O
signing 228 235 2180 2187 O
the 236 239 2188 2191 O
informed 240 248 2192 2200 O
consent 249 256 2201 2208 O
through 257 264 2209 2216 O
30 265 267 2217 2219 B-upper_bound
days 268 272 2220 2224 I-upper_bound
after 273 278 2225 2230 I-upper_bound
the 279 282 2231 2234 O
last 283 287 2235 2239 O
dose 288 292 2240 2244 O
of 293 295 2245 2247 O
study 296 301 2248 2253 O
drug 302 306 2254 2258 O

For 0 3 2259 2262 O
other 4 9 2263 2268 O
targeted 10 18 2269 2277 B-treatment
therapy 19 26 2278 2285 I-treatment
agents 27 33 2286 2292 I-treatment
, 33 34 2292 2293 O
the 35 38 2294 2297 O
washout 39 46 2298 2305 O
period 47 53 2306 2312 O
will 54 58 2313 2317 O
be 59 61 2318 2320 O
5 62 63 2321 2322 O
half 64 68 2323 2327 O
- 68 69 2327 2328 O
lives 69 74 2328 2333 O
, 74 75 2333 2334 O
prior 76 81 2335 2340 O
to 82 84 2341 2343 O
start 85 90 2344 2349 O
of 91 93 2350 2352 O
treatment 94 103 2353 2362 B-treatment
on 104 106 2363 2365 O
study 107 112 2366 2371 O

Histologically 0 14 2372 2386 O
and/or 15 21 2387 2393 O
cytologically 22 35 2394 2407 O
confirmed 36 45 2408 2417 O
, 45 46 2417 2418 O
non 47 50 2419 2422 B-cancer
- 50 51 2422 2423 I-cancer
small 51 56 2423 2428 I-cancer
cell 57 61 2429 2433 I-cancer
lung 62 66 2434 2438 I-cancer
cancer 67 73 2439 2445 I-cancer
( 74 75 2446 2447 I-cancer
NSCLC 75 80 2447 2452 I-cancer
) 80 81 2452 2453 I-cancer
of 82 84 2454 2456 O
adenocarcinoma 85 99 2457 2471 B-cancer
histology 100 109 2472 2481 O
at 110 112 2482 2484 O
the 113 116 2485 2488 O
time 117 121 2489 2493 O
of 122 124 2494 2496 O
initial 125 132 2497 2504 O
diagnosis 133 142 2505 2514 O

Intra 0 5 2515 2520 B-clinical_variable
- 5 6 2520 2521 I-clinical_variable
ocular 6 12 2521 2527 I-clinical_variable
pressure 13 21 2528 2536 I-clinical_variable
> 22 23 2537 2538 O
21 24 26 2539 2541 B-lower_bound
mmHg 27 31 2542 2546 I-lower_bound
, 31 32 2546 2547 O
or 33 35 2548 2550 O
uncontrolled 36 48 2551 2563 O
glaucoma 49 57 2564 2572 B-chronic_disease
( 58 59 2573 2574 O
irrespective 59 71 2574 2586 O
of 72 74 2587 2589 O
intra 75 80 2590 2595 O
- 80 81 2595 2596 O
ocular 81 87 2596 2602 O
pressure 88 96 2603 2611 O
) 96 97 2611 2612 O

Known 0 5 2613 2618 O
actionable 6 16 2619 2629 O
mutations 17 26 2630 2639 O
( 27 28 2640 2641 O
e.g. 28 32 2641 2645 O
, 32 33 2645 2646 O
EGFR 34 38 2647 2651 B-clinical_variable
, 38 39 2651 2652 O
ALK 40 43 2653 2656 B-clinical_variable
, 43 44 2656 2657 O
ROS1 45 49 2658 2662 B-clinical_variable
) 49 50 2662 2663 O
, 50 51 2663 2664 O
against 52 59 2665 2672 O
which 60 65 2673 2678 O
there 66 71 2679 2684 O
is 72 74 2685 2687 O
available 75 84 2688 2697 O
treatment 85 94 2698 2707 B-treatment

Major 0 5 2708 2713 B-treatment
surgical 6 14 2714 2722 I-treatment
procedure 15 24 2723 2732 O
within 25 31 2733 2739 O
21 32 34 2740 2742 B-upper_bound
days 35 39 2743 2747 I-upper_bound
prior 40 45 2748 2753 I-upper_bound
to 46 48 2754 2756 O
enrollment 49 59 2757 2767 O

Males 0 5 2768 2773 B-gender
of 6 8 2774 2776 O
child 9 14 2777 2782 O
bearing 15 22 2783 2790 O
potential 23 32 2791 2800 O
must 33 37 2801 2805 O
agree 38 43 2806 2811 B-contraception_consent
to 44 46 2812 2814 I-contraception_consent
practice 47 55 2815 2823 I-contraception_consent
effective 56 65 2824 2833 I-contraception_consent
barrier 66 73 2834 2841 I-contraception_consent
contraception 74 87 2842 2855 I-contraception_consent
during 88 94 2856 2862 O
the 95 98 2863 2866 O
entire 99 105 2867 2873 O
study 106 111 2874 2879 O
treatment 112 121 2880 2889 B-treatment
period 122 128 2890 2896 O
and 129 132 2897 2900 O
through 133 140 2901 2908 O
6 141 142 2909 2910 B-lower_bound
months 143 149 2911 2917 I-lower_bound
) 149 150 2917 2918 O
after 151 156 2919 2924 O
the 157 160 2925 2928 O
last 161 165 2929 2933 O
dose 166 170 2934 2938 O
of 171 173 2939 2941 O
study 174 179 2942 2947 O
drug 180 184 2948 2952 O
, 184 185 2952 2953 O
( 186 187 2954 2955 O
includes 187 195 2955 2963 O
males 196 201 2964 2969 B-gender
surgically 202 212 2970 2980 B-treatment
sterilized 213 223 2981 2991 I-treatment
( 224 225 2992 2993 O
i.e. 225 229 2993 2997 O
status 230 236 2998 3004 O
post 237 241 3005 3009 B-treatment
vasectomy 242 251 3010 3019 I-treatment
) 251 252 3019 3020 O

Measurable 0 10 3021 3031 O
disease 11 18 3032 3039 O
as 19 21 3040 3042 O
defined 22 29 3043 3050 O
by 30 32 3051 3053 O
RECIST 33 39 3054 3060 O
v1.1 40 44 3061 3065 O
criteria 45 53 3066 3074 O
. 53 54 3074 3075 O
Baseline 55 63 3076 3084 O
measurements 64 76 3085 3097 O
and 77 80 3098 3101 O
evaluation 81 91 3102 3112 O
of 92 94 3113 3115 O
ALL 95 98 3116 3119 B-cancer
sites 99 104 3120 3125 O
of 105 107 3126 3128 O
disease 108 115 3129 3136 O
must 116 120 3137 3141 O
be 121 123 3142 3144 O
obtained 124 132 3145 3153 O
within 133 139 3154 3160 O
4 140 141 3161 3162 B-upper_bound
weeks 142 147 3163 3168 I-upper_bound
prior 148 153 3169 3174 I-upper_bound
to 154 156 3175 3177 O
Enrollment 157 167 3178 3188 O

Mixed 0 5 3189 3194 B-cancer
tumors 6 12 3195 3201 I-cancer
will 13 17 3202 3206 O
be 18 20 3207 3209 O
categorized 21 32 3210 3221 O
by 33 35 3222 3224 O
the 36 39 3225 3228 O
predominant 40 51 3229 3240 O
cell 52 56 3241 3245 O
type 57 61 3246 3250 O

Negative 0 8 3251 3259 O
test 9 13 3260 3264 O
for 14 17 3265 3268 O
pregnancy 18 27 3269 3278 B-pregnancy
is 28 30 3279 3281 O
required 31 39 3282 3290 O
for 40 43 3291 3294 O
females 44 51 3295 3302 B-gender
of 52 54 3303 3305 O
child 55 60 3306 3311 O
- 60 61 3311 3312 O
bearing 61 68 3312 3319 O
potential 69 78 3320 3329 O
; 78 79 3329 3330 O
A 80 81 3331 3332 O
female 82 88 3333 3339 O
of 89 91 3340 3342 O
child 92 97 3343 3348 O
bearing 98 105 3349 3356 O
potential 106 115 3357 3366 O
is 116 118 3367 3369 O
any 119 122 3370 3373 O
woman 123 128 3374 3379 B-gender
, 128 129 3379 3380 O
regardless 130 140 3381 3391 O
of 141 143 3392 3394 O
sexual 144 150 3395 3401 O
orientation 151 162 3402 3413 O
or 163 165 3414 3416 O
whether 166 173 3417 3424 O
they 174 178 3425 3429 O
have 179 183 3430 3434 O
undergone 184 193 3435 3444 O
tubal 194 199 3445 3450 O
ligation 200 208 3451 3459 O
, 208 209 3459 3460 O
who 210 213 3461 3464 O
meets 214 219 3465 3470 O
the 220 223 3471 3474 O
following 224 233 3475 3484 O
criteria 234 242 3485 3493 O
: 242 243 3493 3494 O
1 244 245 3495 3496 O
. 245 246 3496 3497 O
has 247 250 3498 3501 O
not 251 254 3502 3505 O
undergone 255 264 3506 3515 O
a 265 266 3516 3517 O
hysterectomy 267 279 3518 3530 B-treatment
or 280 282 3531 3533 O
bilateral 283 292 3534 3543 B-treatment
oophorectomy 293 305 3544 3556 I-treatment
; 305 306 3556 3557 O
or 307 309 3558 3560 O
2 310 311 3561 3562 O
. 311 312 3562 3563 O
has 313 316 3564 3567 O
not 317 320 3568 3571 O
been 321 325 3572 3576 O
naturally 326 335 3577 3586 O
postmenopausal 336 350 3587 3601 O
for 351 354 3602 3605 O
at 355 357 3606 3608 O
least 358 363 3609 3614 O
24 364 366 3615 3617 B-lower_bound
consecutive 367 378 3618 3629 I-lower_bound
months 379 385 3630 3636 I-lower_bound
( 386 387 3637 3638 O
i.e. 387 391 3638 3642 O
, 391 392 3642 3643 O
has 393 396 3644 3647 O
had 397 400 3648 3651 O
menses 401 407 3652 3658 O
at 408 410 3659 3661 O
any 411 414 3662 3665 O
time 415 419 3666 3670 O
in 420 422 3671 3673 O
the 423 426 3674 3677 O
preceding 427 436 3678 3687 B-upper_bound
24 437 439 3688 3690 I-upper_bound
consecutive 440 451 3691 3702 I-upper_bound
months 452 458 3703 3709 I-upper_bound
or 459 461 3710 3712 O
730 462 465 3713 3716 B-upper_bound
days 466 470 3717 3721 I-upper_bound
) 470 471 3721 3722 O

Ophthalmological 0 16 3723 3739 B-chronic_disease
conditions 17 27 3740 3750 I-chronic_disease

Patients 0 8 3751 3759 O
who 9 12 3760 3763 O
progressed 13 23 3764 3774 O
on 24 26 3775 3777 O
such 27 31 3778 3782 O
treatment 32 41 3783 3792 B-treatment
, 41 42 3792 3793 O
i.e. 43 47 3794 3798 O
, 47 48 3798 3799 O
have 49 53 3800 3804 O
developed 54 63 3805 3814 O
acquired 64 72 3815 3823 O
resistance 73 83 3824 3834 O
and 84 87 3835 3838 O
are 88 91 3839 3842 O
no 92 94 3843 3845 O
longer 95 101 3846 3852 O
reasonably 102 112 3853 3863 O
expected 113 121 3864 3872 O
to 122 124 3873 3875 O
derive 125 131 3876 3882 O
therapeutic 132 143 3883 3894 O
benefit 144 151 3895 3902 O
are 152 155 3903 3906 O
eligible 156 164 3907 3915 O
for 165 168 3916 3919 O
the 169 172 3920 3923 O
trial 173 178 3924 3929 O

Prior 0 5 3930 3935 B-treatment
treatment 6 15 3936 3945 I-treatment
with 16 20 3946 3950 I-treatment
chemotherapy 21 33 3951 3963 I-treatment
or 34 36 3964 3966 O
immunotherapy 37 50 3967 3980 B-treatment
within 51 57 3981 3987 O
14 58 60 3988 3990 B-upper_bound
days 61 65 3991 3995 I-upper_bound
prior 66 71 3996 4001 I-upper_bound
to 72 74 4002 4004 O
enrollment 75 85 4005 4015 O

Received 0 8 4016 4024 O
an 9 11 4025 4027 O
investigational 12 27 4028 4043 B-treatment
drug 28 32 4044 4048 I-treatment
within 33 39 4049 4055 O
30 40 42 4056 4058 B-upper_bound
days 43 47 4059 4063 I-upper_bound
of 48 50 4064 4066 O
starting 51 59 4067 4075 O
treatment 60 69 4076 4085 B-treatment
, 69 70 4085 4086 O
or 71 73 4087 4089 O
have 74 78 4090 4094 O
not 79 82 4095 4098 O
recovered 83 92 4099 4108 O
from 93 97 4109 4113 O
side 98 102 4114 4118 O
effects 103 110 4119 4126 O
of 111 113 4127 4129 O
an 114 116 4130 4132 O
investigational 117 132 4133 4148 O
drug 133 137 4149 4153 O

Serious 0 7 4154 4161 O
medical 8 15 4162 4169 B-chronic_disease
or 16 18 4170 4172 O
psychiatric 19 30 4173 4184 B-chronic_disease
illness 31 38 4185 4192 I-chronic_disease
/ 38 39 4192 4193 I-chronic_disease
condition 39 48 4193 4202 I-chronic_disease
likely 49 55 4203 4209 O
in 56 58 4210 4212 O
the 59 62 4213 4216 O
judgment 63 71 4217 4225 O
of 72 74 4226 4228 O
the 75 78 4229 4232 O
Investigator 79 91 4233 4245 O
to 92 94 4246 4248 O
interfere 95 104 4249 4258 O
with 105 109 4259 4263 O
compliance 110 120 4264 4274 O
with 121 125 4275 4279 O
protocol 126 134 4280 4288 O
treatment 135 144 4289 4298 B-treatment
/ 144 145 4298 4299 O
research 145 153 4299 4307 O

Stage 0 5 4308 4313 B-lower_bound
IIIB 6 10 4314 4318 I-lower_bound
- 10 11 4318 4319 O
IV 11 13 4319 4321 B-upper_bound
, 13 14 4321 4322 O
locally 15 22 4323 4330 O
advanced 23 31 4331 4339 O
or 32 34 4340 4342 O
metastatic 35 45 4343 4353 B-cancer
disease 46 53 4354 4361 O
according 54 63 4362 4371 O
to 64 66 4372 4374 O
the 67 70 4375 4378 O
7 71 72 4379 4380 O
th 73 75 4381 4383 O
edition 76 83 4384 4391 O
of 84 86 4392 4394 O
the 87 90 4395 4398 O
AJCC 91 95 4399 4403 O
lung 96 100 4404 4408 B-cancer
cancer 101 107 4409 4415 I-cancer
TNM 108 111 4416 4419 O
classification 112 126 4420 4434 O
system 127 133 4435 4441 O

Subjects 0 8 4442 4450 O
receiving 9 18 4451 4460 O
palliative 19 29 4461 4471 B-treatment
radiation 30 39 4472 4481 I-treatment
to 40 42 4482 4484 O
CNS 43 46 4485 4488 B-chronic_disease
disease 47 54 4489 4496 I-chronic_disease
within 55 61 4497 4503 O
7 62 63 4504 4505 B-upper_bound
days 64 68 4506 4510 I-upper_bound
may 69 72 4511 4514 O
be 73 75 4515 4517 O
eligible 76 84 4518 4526 O
with 85 89 4527 4531 O
PI 90 92 4532 4534 O
approval 93 101 4535 4543 O

